140 related articles for article (PubMed ID: 17140550)
21. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
Darmani NA; Janoyan JJ; Crim J; Ramirez J
Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
[TBL] [Abstract][Full Text] [Related]
22. CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2.
Németh B; Ledent C; Freund TF; Hájos N
Neuropharmacology; 2008 Jan; 54(1):51-7. PubMed ID: 17714744
[TBL] [Abstract][Full Text] [Related]
23. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
Huang CC; Lo SW; Hsu KS
J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity.
Shen M; Thayer SA
Mol Pharmacol; 1998 Sep; 54(3):459-62. PubMed ID: 9730904
[TBL] [Abstract][Full Text] [Related]
25. Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm.
De Vry J; Jentzsch KR
Behav Pharmacol; 2004 Feb; 15(1):13-20. PubMed ID: 15075622
[TBL] [Abstract][Full Text] [Related]
26. Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal Δ
Beggiato S; Borelli AC; Tomasini MC; Morgano L; Antonelli T; Tanganelli S; Cuomo V; Ferraro L
Neurobiol Learn Mem; 2017 Mar; 139():135-143. PubMed ID: 28104530
[TBL] [Abstract][Full Text] [Related]
27. CB(1) cannabinoid receptors inhibit the glutamatergic component of KCl-evoked excitation of locus coeruleus neurons in rat brain slices.
Mendiguren A; Pineda J
Neuropharmacology; 2007 Feb; 52(2):617-25. PubMed ID: 17070872
[TBL] [Abstract][Full Text] [Related]
28. Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
Carroll CB; Zeissler ML; Hanemann CO; Zajicek JP
Neuropathol Appl Neurobiol; 2012 Oct; 38(6):535-47. PubMed ID: 22236282
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Leon A
Glia; 2003 Jan; 41(2):161-8. PubMed ID: 12509806
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoids inhibit network-driven synapse loss between hippocampal neurons in culture.
Kim HJ; Waataja JJ; Thayer SA
J Pharmacol Exp Ther; 2008 Jun; 325(3):850-8. PubMed ID: 18310474
[TBL] [Abstract][Full Text] [Related]
31. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid receptor activation reduces TNFalpha-induced surface localization of AMPAR-type glutamate receptors and excitotoxicity.
Zhao P; Leonoudakis D; Abood ME; Beattie EC
Neuropharmacology; 2010 Feb; 58(2):551-8. PubMed ID: 19654014
[TBL] [Abstract][Full Text] [Related]
33. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
Hampson AJ; Grimaldi M; Axelrod J; Wink D
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8268-73. PubMed ID: 9653176
[TBL] [Abstract][Full Text] [Related]
34. Delta 9-tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture.
Kelley BG; Thayer SA
Neuropharmacology; 2004 Apr; 46(5):709-15. PubMed ID: 14996548
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.
Kim D; Thayer SA
J Neurosci; 2001 May; 21(10):RC146. PubMed ID: 11319244
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.
McMahon LR; Ginsburg BC; Lamb RJ
Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
[TBL] [Abstract][Full Text] [Related]
38. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
McMahon LR; Koek W
Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
[TBL] [Abstract][Full Text] [Related]
39. Effects of delta9-THC and WIN-55,212-2 on place preference in the water maze in rats.
Robinson L; Hinder L; Pertwee RG; Riedel G
Psychopharmacology (Berl); 2003 Feb; 166(1):40-50. PubMed ID: 12488948
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity.
Hansen HH; Krutz B; Sifringer M; Stefovska V; Bittigau P; Pragst F; Marsicano G; Lutz B; Ikonomidou C
Ann Neurol; 2008 Jul; 64(1):42-52. PubMed ID: 18067175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
